Leonard Sank — ORAMED PHARMACEUTICALS Director Compensation (2025)

What they were paid

ORAMED PHARMACEUTICALS Director Compensation Table · the one fiscal year held

In US dollars, as ORAMED PHARMACEUTICALS reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal year	Cash fees	Stock awards	Option awards	Other	Total
FY2025	$38,500	$78,497	$0	$0	$116,997

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ORAMED PHARMACEUTICALS INC. DEF 14A filed August 3, 2026, accession 0001213900-26-084609, and prior-year filings. Open the filing on EDGAR.

How this board is paid

company policy · FY2025

ORAMED PHARMACEUTICALS pays directors a $30,000 cash retainer and $10,000 in RSUs.

Committees

FY2025 · as the proxy prints them

Compensation · Nominating/Governance

The rest of the ORAMED PHARMACEUTICALS board

FY2025 · as the company reported each

Director	Role	FY2025 total
Benjamin Shapiro	Independent Director	$199,973
Dr. Arie Mayer	Independent Director	$218,961
Dr. Daniel Aghion	Independent Director	$228,600
Dr. Miriam Kidron	Director	$0
Yehuda Reznick	Independent Director	$228,598

The full ORAMED PHARMACEUTICALS compensation record

free company brief

This page is one director within ORAMED PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat